Paper published

Energized
Withania somnifera.Built to go the distance.

An energized Ashwagandha root extract designed for calm, strength and resilience — with markedly enhanced, sustained withanolide exposure while its native withanolide profile stays intact.

What do you need? Pick one · 30 seconds

GreenSpace EASI™ platform✦DFT✦Quantum chemistry✦Frequency energization✦Ayurvedic validation✦ GreenSpace EASI™ platform✦DFT✦Quantum chemistry✦Frequency energization✦Ayurvedic validation✦ GreenSpace EASI™ platform✦DFT✦Quantum chemistry✦Frequency energization✦Ayurvedic validation✦ GreenSpace EASI™ platform✦DFT✦Quantum chemistry✦Frequency energization✦Ayurvedic validation✦

Clean label

2.5% total withanolides, native profile unchanged.

Energization enhances absorption without altering ashwagandha’s phytochemical identity.

NocarriersAbsorbs without a delivery vehicle.

NophospholipidsNo lecithin-based delivery system.

Why?

AshwagandhaQA™ (Withania somnifera) is a revered adaptogen in Ayurveda, known for its ability to support stress resilience, hormonal balance, and cognitive function. However, its potential is often limited by poor bioavailability, especially when consumed in conventional extract forms. To harness Ashwagandha’s full benefits, formulators must enhance its bioavailability.

How?

Quantum Ayurveda at Greenspace infuses select Ayurvedic ingredients with a controlled energy load, then locks that energy in a metastable form so it stays “primed” until it meets the body. AshwagandhaQA™ is an energized, highly bioavailable ingredient developed to address this issue.

Clinical outcome

Pharmacokinetic study of AshwagandhaQA™

Randomized
Double-blind
Single-dose
Two-period crossover
16 healthy volunteers
Single 500 mg oral dose
vs Standard Ashwagandha ≥2.5% withanolides

Plasma withanolides over timeIllustrative profile drawn from the reported Cmax and half-life

Peak level in bloodCmax

~86 ng/mL

~15 ng/mL

5.6^×higher levels in the blood, indicating faster or greater absorption

Total exposureAUC₀–∞

~1261 ng·h/mL

~69 ng·h/mL

18^×more withanolides in the system over time

Half-lifet½

~7.3 hours

~1.4 hours

5^×longer in the body — eliminated more slowly, potentially prolonging its effects

Mean residence timeMRT

~12.4 hours

~3 hours

4^×longer in circulation, contributing to sustained circulation and overall bioavailability

AshwagandhaQA™Standard AshwagandhaBars to scale within each row

SourceTahira H. S., Dr. Rakthim, Dr. Muneeb (2026). Pharmacokinetic study of AshwagandhaQA™ versus a standard ashwagandha root extract in healthy humans: a randomized, double-blind, crossover, single-dose study. World Journal of Pharmaceutical Science and Research, 5(2): 176–182. doi:10.5281/zenodo.18439404

Want the full study on your desk?The clinical data, sent to you directly.

Formulation opportunity

Clean-label positioning
Calm + stress-resilience positioning
Sleep and recovery formulations
Sustained 24-hour systemic exposure
Potential once-daily formulation advantage

The buyer takeaway
Same standardized 2.5% withanolides, far greater systemic exposure — and a clean label to match. A compelling way to differentiate premium adaptogen products.

Research record

Peer-reviewed, and published.

Published

Pharmacokinetic Study of AshwagandhaQA™ Versus a Standard Ashwagandha Root Extract in Healthy Humans: A Randomized, Double-Blind, Crossover, Single-Dose Study.

World Journal of Pharmaceutical Science and Research, 2026; 5(2): 176–182